PNC Financial Services Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-397
| Closed | -$2K | – | 4184 |
|
2019
Q4 | $2K | Sell |
397
-2,900
| -88% | -$14.6K | ﹤0.01% | 3848 |
|
2019
Q3 | $16K | Buy |
3,297
+1,344
| +69% | +$6.52K | ﹤0.01% | 3429 |
|
2019
Q2 | $11K | Buy |
1,953
+1,235
| +172% | +$6.96K | ﹤0.01% | 3548 |
|
2019
Q1 | $4K | Sell |
718
-1,190
| -62% | -$6.63K | ﹤0.01% | 3810 |
|
2018
Q4 | $26K | Buy |
1,908
+186
| +11% | +$2.54K | ﹤0.01% | 3200 |
|
2018
Q3 | $33K | Sell |
1,722
-13,434
| -89% | -$257K | ﹤0.01% | 3239 |
|
2018
Q2 | $388K | Sell |
15,156
-2,109
| -12% | -$54K | ﹤0.01% | 1798 |
|
2018
Q1 | $347K | Sell |
17,265
-3,345
| -16% | -$67.2K | ﹤0.01% | 1841 |
|
2017
Q4 | $414K | Buy |
20,610
+11,012
| +115% | +$221K | ﹤0.01% | 1755 |
|
2017
Q3 | $200K | Buy |
9,598
+819
| +9% | +$17.1K | ﹤0.01% | 2144 |
|
2017
Q2 | $130K | Buy |
8,779
+2,794
| +47% | +$41.4K | ﹤0.01% | 2377 |
|
2017
Q1 | $95K | Buy |
5,985
+307
| +5% | +$4.87K | ﹤0.01% | 2525 |
|
2016
Q4 | $72K | Sell |
5,678
-1,596
| -22% | -$20.2K | ﹤0.01% | 2659 |
|
2016
Q3 | $203K | Buy |
7,274
+350
| +5% | +$9.77K | ﹤0.01% | 2088 |
|
2016
Q2 | $242K | Sell |
6,924
-1,710
| -20% | -$59.8K | ﹤0.01% | 1966 |
|
2016
Q1 | $236K | Buy |
8,634
+1,748
| +25% | +$47.8K | ﹤0.01% | 1999 |
|
2015
Q4 | $235K | Buy |
6,886
+6,563
| +2,032% | +$224K | ﹤0.01% | 1980 |
|
2015
Q3 | $9K | Buy |
323
+107
| +50% | +$2.98K | ﹤0.01% | 3734 |
|
2015
Q2 | $10K | Buy |
+216
| New | +$10K | ﹤0.01% | 3816 |
|